(Total Views: 907)
Posted On: 09/16/2019 4:55:43 PM
Post# of 113
$TNXP News Article - Tonix Pharmaceuticals Announces Licensing Agreement with Columbia University for the Development of Recombinant Trefoil Family Factor 2 (rTFF2), or TNX-1700, for the Treatment of Gastric and Pancreatic Cancers https://marketwirenews.com/news-releases/toni...65875.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
